Scope of the Study
The global pharmaceutical ERP software market is expected to grow at a healthy pace during the forecast period, according to the AMA study. Growing demand for real-time visibility across the pharmaceutical industry and increasing demand for forecasting & tracking are expected to be some of the major factors aiding into the growth for the market. However, the market is expected to witness decline in the growth during FY 2020 but it is again expected to rise with a healthy pace after the COVID-19 pandemic is over.
The market study is being classified, by Application (Inventory Management, Sales Management, Accounts Payable & Receivable, HR Management, Project Management, Fixed Assets and Production Management) and major geographies with country level break-up.
SAP (Germany), Oracle (United States), Microsoft (United States), Epicor Software Corporation (United States), Ramco Systems (India), Sage Software Solutions Pvt. Ltd. (United States), IBM (United States), Zoho Corporation (India), Xmplar.in (India), BatchMaster Software (United States), CAMS (India) and Marg Erp Limited (India) are some of the key players profiled in the study.
The vendors in this market are majorly focusing on developing innovative products and solutions in order to cater to the market's demands to remain competitive in the global market. According to the recent global industry crisis due to outbreak of COVID-19 is expected to be one of the major challenges for the vendors of this market as the production and markets of different industries have been shut down for an ambiguous period of time. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Covid-19 Impact on Pharmaceutical ERP Software market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Covid-19 Impact on Pharmaceutical ERP Software market by Type, Application and Region.
On the basis of geography, the market of Covid-19 Impact on Pharmaceutical ERP Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growing Demand for Real-Time Visibility Across Pharma Businesses
- Increasing Demand for Forecasting & Tracking
- Implementation of Artificial Intelligence (AI) & Machine Learning (ML) in ERP Platforms
- Rising Drug Development for Different Antidotes & Medicines
- Opportunities in the Asia Pacific Region Specially from the Countries such as India which is One of the Major Exporters in the Pharma Industries across the World
- Lack of Skilled Professionals
Stringent Worldwide Government Regulations Regarding Shutting Down of Operations Across Different Industries Leading to Slow-down in Growth for Pharmaceutical Developments
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase